Global Behavioural Health Market

Behavioural Health Market Size, Share, Growth Analysis, By Service(Home-Based Treatment Services, Outpatient counselling), By Disorder(Bipolar Disorder, Anxiety Disorder) - Industry Forecast 2024-2031

Report ID: SQMIG35D2008 | Region: Global | Published Date: July, 2001
Pages: 165 | Tables: 69 | Figures: 75

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

The behavioral health market is projected to grow at a CAGR of 3.10% during the forecast period of 2022-2029.

Limited access to mental health providers, lack of trained mental health care provider, low awareness regarding treatment option among general population and limitation of primary care services are major challenges for the Behavioural Health Market.

Behavioural Health Market size was valued at USD 1.99 billion in 2019 and is poised to grow from USD 2.22 billion in 2023 to USD 5.04 billion by 2031, growing at a CAGR of 10.8% in the forecast period (2024-2031).

According to the research, prominent manufacturers are always improving their goods in order to attract new clients and increase their Service range in order to enhance their market position in all key nations. Besides, the rise in public and private support for specialized research provide market participants with profitable options. Furthermore, the increasing number of Service approvals, current implant developments, and technical improvements are some of the other aspects expected to contribute to a positive market outlook. 'Acadia Healthcare', 'Behavioral Health Network, Inc.', 'Universal Health Services (UHS)', 'Magellan Health', 'Cigna Corporation', 'UnitedHealth Group', 'Anthem, Inc.', 'Aetna Inc.', 'Beacon Health Options', 'Optum, Inc.', 'Humana Inc.', 'Centene Corporation', 'Molina Healthcare, Inc.', 'WellCare Health Plans, Inc.', 'Bristol-Myers Squibb', 'Pfizer Inc.', 'Johnson & Johnson', 'Eli Lilly and Company', 'GlaxoSmithKline plc', 'Sanofi S.A.'

Depression, eating disorders, anxiety, bipolar disorder, schizophrenia, alcohol use disorders, and post-traumatic stress disorders are the disorder types defined in the worldwide behavioural health industry. In 2021, the depression sector accounted for a sizable portion of the worldwide market. From 2023 to 2030, the category is predicted to grow at a rapid pace. The market is being propelled by an increase in the number of depression cases caused by negative thoughts, socioeconomic strain, and significant sickness.

Prioritizing Patient Data and Privacy: On the regulatory front, the rising use of telehealth has compelled providers to prioritise patient data protection and privacy. Electronic health records (EHR) already have particular regulatory demands; telehealth services and platforms must comply with new and existing health regulatory frameworks if they are to protect your practise from harsh fines. 

In 2022, Europe led the worldwide behavioural health market. The region's market is largely driven by an increase in the prevalence of behavioural health problems such as depression and anxiety. An increase in the number of drug addiction and alcohol abuse disorder cases is also expected to fuel the regional behavioural health market. Furthermore, the existence of significant competitors and developments such as acquisitions, collaborations, and the opening of new facilities are expected to boost the European behavioural health market.

Related Reports

Livestock Animal Rehabilitation Services Market
Buy Now GET FREE SAMPLE
Hospital Lighting Market
Buy Now GET FREE SAMPLE
Healthcare Third-party Logistics Market
Buy Now GET FREE SAMPLE
Healthcare Supply Chain BPO Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Behavioural Health Market

Product ID: SQMIG35D2008

$5,300
BUY NOW GET FREE SAMPLE